President Donald Trump weighed in on the tragic midair collision that occurred Wednesday between a passenger jet and a Black Hawk helicopter, resulting in both aircraft crashing into the Potomac River ...
HOUSTON (Reuters) - Exxon Mobil (NYSE: XOM) on Friday beat Wall Street's estimate for fourth-quarter profit as higher oil and ...
Investing.com -- RBC Capital Markets has initiated coverage on Greencore Group (LON: GNC) with an 'outperform' rating, citing the company's improving profitability, growth initiatives, and potential ...
Sheinbaum and officials in her administration have suggested Mexico would retaliate if Trump implemented tariffs with a set of their own on U.S. exports, and warned that such tit-for-tat measures ...
Capital Economics recalled the final year of the "dotcom bubble," when US stocks began to underperform compared to their ...
Shares of Olin Corporation (NYSE: OLN) declined 10% today after the company released a weaker-than-expected profit outlook for the first quarter of 2025. The chem ...
TYSONS CORNER, VA - MicroStrategy Incorporated (NASDAQ:MSTR), a prominent business intelligence firm, disclosed the pricing details for its recent offering of perpetual strike preferred stock on ...
Jefferies made key adjustments to its sector strategy, upgrading Financials to Overweight while downgrading both Materials ...
Our Yancoal Australia Ltd share price forecast data is based on consensus analyst prediction, covering public companies earnings per share and revenue. Assess the Yancoal Australia share price ...
TOKYO (Reuters) - Weeks after Japan revealed details of a landmark energy plan partly designed to keep up with an expected AI surge, the shock rise of Chinese startup DeepSeek has upended conventional ...
Premier1 Lithium Ltd made exploration progress at its Yalgoo Project in the December quarter, where a high-resolution magnetic survey identified key gold prospects. The company also completed a ...
Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...